Digital Look

Welcome to Digital Look++,
you are not logged in

Eden Research (EDEN)

Pharma and Biotech

3.90p

Select chart: EPS | Dividend | Revenue

Period Ending	Period	Revenue (£m)	Pre-tax (£m)	EPS	Dividend
30-Jun-24	Interim	1.89	(1.31)	(0.17)p	n/a

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-19	2.05	(1.48)	(0.55)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-20	1.37	(2.55)	(0.66)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-21	1.23	(3.40)	(0.73)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-22	1.83	(2.57)	(0.59)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-23	3.19	(6.92)	(1.54)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-24	4.30	(2.10)	(0.30)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-25	5.00	(1.80)	(0.30)p	n/a	n/a	n/a	n/a	0.0%

	5 Yr High	5 Yr Low	5 Yr Avg	Curr / Avg
Latest	n/a	n/a	n/a	0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

Find out about IFRS and how this affects the financial infomation for all UK companies.